Athos Capital LTD Iveric Bio, Inc. Transaction History
Athos Capital LTD
- $311 Million
- Q3 2024
A detailed history of Athos Capital LTD transactions in Iveric Bio, Inc. stock. As of the latest transaction made, Athos Capital LTD holds 200,000 shares of ISEE stock, worth $0. This represents 6.14% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$0% of portfolio
6.14%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ISEE
# of Institutions
7Shares Held
250KCall Options Held
40KPut Options Held
0-
Monarch Partners Asset Management LLC187KShares$01.22% of portfolio
-
Pictet Asset Management Sa Geneva 73, V825KShares$00.0% of portfolio
-
Jefferies Group LLC New York, NY19.5KShares$00.0% of portfolio
-
Aevitas Wealth Management, Inc.17.8KShares$00.22% of portfolio
-
Endurance Wealth Management, Inc.1.5KShares$00.01% of portfolio
About IVERIC bio, Inc.
- Ticker ISEE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,078,000
- Description
- IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...